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Objectives: To investigate the epidemiological traits of carbapenem-non-susceptible Acinetobacter baumannii
(CNSAB) and the usefulness of phylogenetic grouping based on partial rpoB gene sequencing in defining the
epidemiological traits of CNSAB.
Methods: A total of 547 non-duplicate clinical isolates of Acinetobacter spp. were collected from 19 hospitals in
Korea in 2008. Detection of genes encoding OXA carbapenemases and metallo-b-lactamases was performed
by PCR. The epidemiological relationships of the isolates were investigated by multilocus sequence typing and
repetitive-sequence-based PCR. The 450 bp sequence (zone 2) of the rpoB gene was amplified and sequenced.
Results: Molecular characterization of the 272 CNSAB isolates identified five sequence types (STs): ST92, ST75,
ST137, ST138 and ST69. The first four of these STs were clustered into clonal complex (CC) 92, sharing alleles
at six of seven housekeeping gene loci; ST69 shared alleles at five of seven loci. CNSAB of CC92 carried the
blaOXA-23 gene (n¼169), the blaOXA-51-like gene preceded by ISAba1 (n¼89) or both (n¼14). Notably, all
CNSAB isolates carried a G428T substitution in zone 2 of the rpoB gene.
Conclusions: CNSAB isolates of CC92 with the G428T substitution in zone 2 of the rpoB gene are disseminated
nationwide in Korea. A. baumannii with the single nucleotide substitution may be more likely to acquire carba-
penem resistance than are other isolates.
Keywords: clonal complex 92, European clone II, multilocus sequence typing
Introduction
The genus Acinetobacter consists of 22 nomenspecies and at
least 11 additional putative species.1 Acinetobacter baumannii
is an opportunistic pathogen and is the most common cause
of serious nosocomial infections within the genus Acinetobacter,
especially those found in intensive care units (ICUs).1 Carbape-
nems are recommended as first-line therapy in the treatment
of serious infections caused by A. baumannii resistant to
oxyimino-cephaolosporins. The recent dissemination of
carbapenem-non-susceptible A. baumannii (CNSAB) in many
parts of the world is therefore very worrisome, resulting in
limited antimicrobial treatment options.
Worldwide dissemination of carbapenem-resistant European
clones I and II (EU-I and EU-II) has been reported by several
authors. Mugnier et al.2 identified 8 EU-I isolates of sequence
type (ST) 25, ST44 or two novel STs, as well as 10 EU-II isolates
of ST92 (ST22 was moved to ST92 after an update of allelic
profiles at the web site http://pubmlst.org) or ST118 (moved
from ST53) among 20 A. baumannii isolates carrying the
blaOXA-23 gene originating from 15 countries. Wide dissemination
of CNSAB isolates of ST92 and its single-locus variants has also
been described in China and Korea.3,4 Nemec et al.5 found that
20 isolates carrying blaOXA-58-like, blaOXA-24-like or blaOXA-51-like
genes preceded by ISAba1 from 23 A. baumannii isolates for
which carbapenem MICs were ≥8 mg/L isolated from the
Czech Republic belonged to EU-II. Dissemination of EU-II isolates
carrying the blaOXA-58 gene in ICUs in Rome has also been
reported.6 In contrast, Kulah et al.7 reported that multiple
clones of A. baumannii carrying the blaOXA-58 gene were respon-
sible for a sustained outbreak that occurred in a hospital in
Turkey; however, those isolates were not associated with the
A. baumannii EU-I, EU-II or EU-III strains.
Scola et al.8 demonstrated the usefulness of RNA polymerase
b-subunit (rpoB) gene sequencing in the differentiation and
identification of Acinetobacter spp. Ko et al.9 reported that
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A. baumannii isolates could be divided into three subgroups (I, II
or III) based on phylogenetic grouping inferred from the
sequence of a variable region, zone 2, in the rpoB gene. Further-
more, they reported that the grouping correlated with antimicro-
bial resistance profiles. While most isolates of subgroup I were
susceptible to colistin and polymyxin B, many isolates of sub-
groups II and III exhibited resistance to these drugs. However,
they did not focus on correlations between the grouping and car-
bapenem resistance profiles in A. baumannii.
The aims of this study were to define the epidemiological
traits of CNSAB isolates from clinical specimens from patients
hospitalized at 19 different hospitals in Korea. We also aimed
to investigate the usefulness of phylogenetic grouping based
on partial rpoB gene sequencing in defining the epidemiological
traits of CNSAB.
Materials and methods
Bacterial isolates
A total of 547 clinical isolates of Acinetobacter spp. were collected from
19 different hospitals in six provinces of Korea in 2008 (Figure S1, avail-
able as Supplementary data at JAC Online). During those periods, the iso-
lates were consecutively collected at each hospital and recovered as one
isolate per patient. The strains were isolated from blood, sputum, wound
and urine specimens. The isolates were identified using the ATB 32 GN
system (bioMe´rieux, Marcy l’E´toile, France) and 16S–23S rRNA intergenic
spacer region sequencing.10
Antimicrobial susceptibility testing
Antibiotic-containing discs (Becton Dickinson, Sparks, MD, USA) were used
for routine antibiograms in a disc diffusion assay. The modified Hodge
test and the imipenem and EDTA–sodium mercaptoacetic acid double-
disc synergy (IEDDS) test were performed on MacConkey agar plates as
described previously for the screening of carbapenemases and
metallo-b-lactamases (MBLs), respectively.11 MICs of colistin were deter-
mined using the agar dilution method according to CLSI guidelines.12
A. baumannii ATCC 19606 and Acinetobacter genomospecies 14TU ATCC
17905 were used as control strains.
Identification of carbapenemase genes
Whole-cell lysates of the clinical isolates were used as templates for PCR
amplification. PCR experiments were carried out to detect the genes
encoding MBLs (IMP-1 variants, VIM-2 variants and SIM-1) and OXA car-
bapenemases (OXA-23-like, OXA-24-like, OXA-51-like and OXA-58-like) as
described previously.13 A simple two-step PCR experiment was performed
to sequence the upstream region of the blaOXA-51-like gene as described
previously.14 PCR products were subjected to direct sequencing with an
automatic sequencer (Model 3730xl; Applied Biosystems, Weiterstadt,
Germany).
PFGE and Southern blotting
Plugs containing whole genomic DNA of the isolates were digested with
S1 nuclease or I-CeuI. DNA fragments were separated using PFGE with a
CHEF-DRII device (Bio-Rad, Hercules, CA, USA). PFGE was performed at
6 V/cm for 20 h with pulse times ranging from 9 to 90 s at a temperature
of 148C. The gels with S1 nuclease-treated linearized plasmids and
I-CeuI-digested chromosomal DNA were blotted onto nylon membranes
(Bio-Rad) and hybridized with probes specific for the blaOXA-23 gene or 16S
rDNA. The probes were obtained via PCR experiments as described above.
Probe labelling, hybridization and detection were performed with the
DIG DNA Labeling and Detection Kit (Roche Diagnostics, Indianapolis,
IN, USA).
Repetitive-sequence-based PCR (Rep-PCR)
Rep-PCR experiments were performed using the DiversiLab system (bio-
Merieux, Grenoble, France) according to the manufacturer’s instructions,
to investigate the clonal relatedness of A. baumannii isolates. Results
were analysed with DiversiLab software using the Kullback–Leibler
method to determine distance matrices and the unweighted pair group
method with arithmetic averages to create a dendrogram. Isolates
showing .95% similarity were considered to be related.15
Phylogenetic grouping based on partial
rpoB gene sequencing
The 450 bp sequence (zone 2) of the rpoB gene was amplified using the
primers Ac1005F (5′-GTGATAARATGGCBGGTCGT-3′) and Ac1598R
(5′-CGBGCRTGCATYTTGTCRT-3′) as previously described.8 The phyloge-
netic relationship based on the rpoB zone 2 sequence was estimated
using the neighbour-joining method in molecular evolutionary genetic
analysis software.
Multilocus sequence typing (MLST)
MLST was performed using the method of Bartual et al.16 Fragments of
seven housekeeping genes (gltA, gyrB, gdhB, recA, cpn60, gpi and rpoD)
were amplified by PCR and sequenced. Two primer sets were redesigned:
gpi2-F (5′-AATACCGTGGTGCTACG-3′) and gpi2-R (5′-TTCAGGAGCAATCC
CCCACT-3′); rpoD2-F (5′-CGAATYGCATTGCAAAACG-3′) and rpoD2-R
(5′-CNGCAATYTTTTGYTGGAA-3′). Allele numbers were assigned an ST
after the distinct allele sequences were submitted to a dedicated data-
base (http://pubmlst.org). A clonal complex (CC) was used to assess the
genetic relatedness of the STs; the most stringent definition—sharing
alleles at six of seven loci—was used.17 MLST described by Diancourt
et al.18 was performed for representative strains allocated to the STs
associated with CNSAB. Allelic profiles of seven housekeeping genes
(cpn60, fusA, gltA, pyrG, recA, rplB and rpoB) were analysed using Acine-
tobacter MLST database (http://www.pasteur.fr/recherche/genopole/PF8/
mlst/).
Results
Acinetobacter spp.
The clinical isolates of Acinetobacter spp. (n¼547) were ident-
ified as A. baumannii (n¼388), Acinetobacter genomospecies
13TU (n¼82), Acinetobacter genomospecies 3 (n¼62), Acineto-
bacter bereziniae (n¼13) and Acinetobacter genomospecies
14TU (n¼2) (Table 1).
Grouping of A. baumannii isolates based on partial
rpoB gene sequencing
A phylogenetic tree clustered the 388 A. baumannii isolates into
five groups according to the rpoB zone 2 sequence using the
neighbour-joining method (Figure 1). The group A isolate was
defined as that carrying the same nucleotide sequence in zone
2 of the rpoB gene as that carried by the A. baumannii ATCC
19606 reference strain. The group B isolate was defined as that
with a G-to-T substitution at the 428th nucleotide in zone 2
A. baumannii of clonal complex 92
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compared with the A. baumannii ATCC 19606 reference strain
sequence. Isolates belonging to subgroup B-0 had only one
G428T substitution. Group C, D and E isolates were defined as
those with a C449T, A407G or G116A substitution, respectively,
in zone 2 compared with the A. baumannii ATCC 19606 reference
strain sequence (Table 1).
Carbapenem resistance
While 70% (272/388) of A. baumannii isolates exhibited inter-
mediate susceptibility or resistance to imipenem and/or merope-
nem, the majority of non-baumannii Acinetobacter (NBA) isolates
were susceptible to these drugs (Table 1). Most CNSAB (266/272)
showed positive results on the modified Hodge test; however,
none had positive results on the IEDDS test. The blaOXA-23 gene
was detected in 169/272 CNSAB isolates, while the ISAba1
element associated with the blaOXA-51-like gene was detected
in 89/272 isolates. Fourteen isolates, all of which were collected
from the same hospital, carried both genes. Genes encoding
OXA-24-like and OXA-58-like carbapenemases or MBLs were
not detected in the A. baumannii isolates. Interestingly, all 272
CNSAB isolates belonged to subgroup B-0. However, some (37/
309) isolates belonging to subgroup B-0 were susceptible to
carbapenems.
Most (10/12) of the carbapenem-non-susceptible NBA iso-
lates showed positive results on the IEDDS test, suggesting the
production of MBLs. The blaIMP-1 and the blaVIM-2 genes were
detected in six and four of these NBA isolates, respectively.
With the exception of an Acinetobacter genomospecies 3
isolate carrying the blaOXA-23 gene, no genes encoding OXA car-
bapenemases were detected in any of the NBA isolates.
Location of the blaOXA-23 gene
A probe specific for the blaOXA-23 gene hybridized with 100–
150 kb I-CeuI chromosomal fragments from A. baumannii and
Acinetobacter genomospecies 3 isolates, but not with S1
nuclease-treated linearized plasmids. The 16S rDNA probe also
hybridized with the same chromosomal fragments, suggesting
the presence of the blaOXA-23 gene on the chromosome rather
than on a plasmid (data not shown).
Clonal relationship
Results of rep-PCR experiments on the 388 A. baumannii isolates
are shown in Figure 2, illustrating that the A. baumannii isolates
were clustered into 57 distinct band patterns, using a clonal
relationship index of .95% as a threshold. All 272 CNSAB iso-
lates belonged to one of three band patterns (17, 18 or 19).
Table 1. Antimicrobial susceptibilities and A. baumannii groups according to substitution in zone 2 of the rpoB gene sequence
Species (no. of isolates) Substitutionb
IPM (breakpoints, mm)a MEM (breakpoints, mm) CST (MIC, mg/L)
R (≤13) I (14–15) S (≥16) R (≤13) I (14–15) S (≥16) R (≤2) S (≥4)
A. baumannii, group (388)
B (320)
B-0c G428T 221 23 65 270 2 37 0 309
B-1 G428T, C292T 0 0 4 0 0 4 0 4
B-2 G428T, C292T, G89C 0 0 5 0 0 5 0 5
B-3 G428T, T431A 0 0 2 0 0 2 0 2
C (36)
C-0 C449T 0 0 8 0 0 8 0 8
C-1 C449T, C269A 0 0 23 0 0 23 0 23
C-2 C449T, C239T 0 0 3 0 0 3 0 3
C-3 C449T, C114T 0 0 2 0 0 2 0 2
E (13)
E-0 G116A 0 0 12 0 0 12 0 12
E-1 G116A, C449T 0 0 1 0 0 1 0 1
D (5) A407G 0 0 5 0 0 5 0 5
A (14) 0 0 14 0 0 14 1 13
Acinetobacter genomospecies 13TU (82) 2 2 78 4 0 78 0 82
Acinetobacter genomospecies 3 (62) 8 0 54 8 0 54 0 62
A. bereziniae (13) 0 0 13 0 0 13 1 12
Acinetobacter genomospecies 14TU (2) 0 0 2 0 0 2 2 0
IPM, imipenem; MEM, meropenem; CST, colistin; R, resistant; I, intermediate; S, susceptible.
aCLSI breakpoints were applied for the interpretation of the results.
bThe reference sequence of A. baumannii ATCC 19606 was defined as group A.
cThere was a significant difference (P,0.001) in carbapenem susceptibility between the B-0 group (88.0%) and non-B-0 groups (0%) by x2 test
(Fisher’s exact test) using SAS 9.1.3 (SAS Institute Inc., Cary, NC, USA).
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These band patterns were similar to those of the EU-II control
strain described by Higgins et al.19 A total of 57 different STs
were identified in 388 A. baumannii isolates using MLST exper-
iments by the method of Bartual et al.,16 and the 272 CNSAB iso-
lates were classified into five STs (ST92, ST75, ST138, ST137 and
ST69; Figure 2). However, the isolates of the aforementioned five
STs were identified as an identical ST, ST2 (2-2-2-2-2-2-2), by the
MLST method described by Diancourt et al.18
Many (159/272) CNSAB isolates were identified as ST92
including 76 isolates carrying the blaOXA-23 gene, 69 isolates car-
rying the ISAba1 element associated with the blaOXA-51-like gene
and 14 isolates carrying both. One hundred and five isolates car-
rying the blaOXA-23 gene (n¼93) or the ISAba1 element associ-
ated with the blaOXA-51-like gene (n¼12) were identified as
ST75 (n¼64), ST137 (n¼3) or ST138 (n¼38) single-locus var-
iants of ST92. The remaining eight isolates carrying the ISAba1
element associated with the blaOXA-51-like gene were identified
as ST69, a double-locus variant of ST92.
Susceptibility to colistin
All but four Acinetobacter spp. isolates exhibited susceptibility to
colistin. Only one of 403 A. baumannii isolates (MIC 8 mg/L) and
one of 13 A. bereziniae isolates (MIC 8 mg/L) showed low-level
resistance to colistin. None of the 82 Acinetobacter genomospe-
cies 13TU isolates or of the 62 Acinetobacter genomospecies
3 isolates showed resistance to colistin (Table 1). However,
both Acinetobacter genomospecies 14TU isolates showed high-
level resistance to colistin (MIC 32 mg/L). Interestingly, the Acine-
tobacter genomospecies 14TU ATCC 17905 reference strain also
showed high-level resistance to the drug (MIC 64 mg/L).
Discussion
The 272 CNSAB isolates were identified as ST92, one of its single-
locus variants (ST75, ST138 or ST137) or its double-locus variant
(ST69). ST92 and its single-locus variants can be clustered into a
B-2 group
B-0 group
B-3 group
B-1 group
A. baumannii ATCC19606
A group
D group
E group
E-1 group
C group
C-1 group
C-3 group
C-2 group
genomosp. 13TU ATCC17903
A. calcoaceticus strain CIP 81.8
genomosp. 3 strain CIP 70.15
genomosp. 14TU ATCC17905
genomosp. 10 strain CIP 70.12
A. haemolyticus strain CIP 64.3
A. ursingii strain NIPH3649
0.02
A. baumannii group B (n = 320)
A. baumannii group A (n = 14)
A. baumannii group D (n = 5)
A. baumannii group E (n = 13)
A. baumannii group C (n = 36)
50
86
96
66
99
36
22
23
29
49
43
Figure 1. Phylogenetic tree of 388 isolates of A. baumannii inferred from zone 2 sequencing of the rpoB gene. This tree was grouped using the
neighbour-joining method in molecular evolutionary genetic analysis software. Values on the branches of the clusters represent the results of
bootstrapping analysis.
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Isolates
IJ01
SC19
CHA42
IJ40
CYH28
KSM07
GY26
YN04
CS18
IJ35
CN10
CN15
YMM14
CHA27
CHA26
CHA33
KSM20
GY12
YMC31
WJ05
CHA39
CYY17
CYY24
WJ44
YMC11
IJ22
KSM29
GY13
GY20
GM32
CHA15
YN45
YMM4
YMC26
MJ15
KS49
CHA45
KSM22
KY14
KS30
SC03
KSS21
CYM22
KMC07
CHA51
CS30
CHA18
KY23
CHA27
CYM23
KS47
YMC42
KSS36
CNM10
CYH13
CHA50
WJ02
KSS15
YMM05
MJ12
CCH15
CHA31
MJ26
KSM11
CS41
CHA39
CYH26
IJ02
20 40 60 80 100
% Similarity
Rep-PCR gltA gyrB gdhB recA cpn60 gpi STrpoD rpoB type  no. of
isolates
Susceptible
blaOXA-23
blaOXA-51 Aba1-blaOXA-51-like
blaOXA-23+ISAba1-
no. (%) of isolates with carbapenem susceptibility
Carbapenem-resistance determinant 
 1 1 3 65 45 4 4 26 148* B-1 1 1 0 0 0
 1 1 48 65 45 4 90 26 171* B-0 1 1 0 0 0
 1 1 48 65 45 4 90 26 171* E-0 1 1 0 0 0
 2 21 12 2 28 1 86 4 161* C-1 1 1 0 0 0
 3 21 48 58 42 36 83 4 176* B-1 1 1 0 0 0
 4 35 60 77 11 26 11 48 182* B-1 1 1 0 0 0
 5 36 31 70 28 4 54 4 184* B-0 1 1 0 0 0
 6 2 38 42 1 1 4 49 150* B-1 1 1 0 0 0
 7 2 38 42 1 1 4 49 150* E-0 1 1 0 0 0
 8 1 15 13 12 4 14 2 146* C-0 1 1 0 0 0
 9 1 15 13 12 4 14 2 146* C-0 2 2 0 0 0
 10 1 15 13 12 4 14 2 146* C-0 2 2 0 0 0
 11 1 15 13 12 4 12 2 20 C-0 1 1 0 0 0
 12 1 31 79 43 4 25 50 157* C-3 1 1 0 0 0
 13 1 31 79 43 4 25 50 157* C-3 1 1 0 0 0
 14a 21 35 2 28 1 85 4 158* C-1 1 1 0 0 0
 14a 21 35 2 28 1 52 4 145* C-1 1 1 0 0 0
 15 1 15 12 6 28 59 32 140* A 2 2 0 0 0
 16 21 35 2 28 1 52 4 145* C-1 1 1 0 0 0
 17a 1 3 3 2 2 7 3 92 B-0 183 24 (6) 76 (20) 69 (18) 14 (4)
 17a 1 47 67 28 1 10 6 143* B-3 1 1 0 0 0
 17a 1 3 3 2 2 12 3 137 B-0 3 0 0 3 0
 17a 1 46 3 2 2 58 3 69 B-0 8 0 0 8 (2) 0
 17b 1 3 3 2 2 50 3 138 B-0 3 1 1 1 0
 17b 1 3 3 2 2 11 3 75 B-0, E-1 60 1  55 (14) 4 (1) 0
 17b 1 47 3 2 2 7 30 141* A 1 1 0 0 0
 17b 1 15 81 1 1 72 45 152* C-1 1 1 0 0 0
 18 1 3 3 2 2 11 3 75 B-0 5 0 2 3 0
 18 1 12 12 11 4 10 3 17 B-2 5 5 0 0 0
 18 1 3 3 2 2 50 3 138 B-0, E-0 37 1  35 (9) 1 0
 19a 1 15 2 28 1 25 32 156* C-1 6 6 0 0 0
 19b 1 56 2 44 1 52 6 160* C-1 1 1 0 0 0
 19c 1 47 67 28 1 82 6 149* B-3 1 1 0 0 0
 19d 1 15 2 28 1 52 32 110 C-1 4 4 0 0 0
 19e 1 15 2 28 1 52 32 110 C-1 2 2 0 0 0
 20 33 21 12 49 1 54 7 177* C-0 1 1 0 0 0
 21 1 15 2 28 1 52 32 110 C-1 1 1 0 0 0
 22a 21 12 2 28 32 83 4 151* C-1 2 2 0 0 0
 22a 21 35 2 28 1 84 4 153* C-1 1 1 0 0 0
 22b 21 55 13 28 1 84 2 154* C-0 1 1 0 0 0
 23 37 53 13 47 32 64 52 185* B-0 1 1 0 0 0
 24 1 15 12 6 28 59 3 139* A 1 1 0 0 0
 25 1 57 78 12 1 10 51 159* C-2 1 1 0 0 0
 26 1 57 78 12 1 25 51 155* C-2 1 1 0 0 0
 27 1 57 78 12 1 10 51 159* C-2 1 1 0 0 0
 28 33 12 40 26 32 83 5 167* D 1 1 0 0 0
 29 33 12 40 26 32 84 5 164* D 1 1 0 0 0
 30 33 12 40 26 32 91 5 163* D 1 1 0 0 0
 31 33 12 40 26 25 84 5 165* D 1 1 0 0 0
 32 33 12 40 26 32 87 5 166* D 1 1 0 0 0
 33 35 62 75 28 35 7 30 179* A 2 2 0 0 0
 34 1 17 82 39 1 92 7 175* A 3 3 0 0 0
 35a 1 17 81 1 1 91 26 183* B-0 1 1 0 0 0
 35b 1 54 62 31 4 55 45 147* E-0 3 3 0 0 0
 35c 1 3 15 2 2 7 3 106 B-0 1 1 0 0 0
 36 1 58 29 2 4 9 53 173* B-0 1 1 0 0 0
 37a 38 59 80 48 18 58 43 186* B-0 1 1 0 0 0
 37b 40 1 83 6 4 7 3 162* B-0 3 3 0 0 0
 38 31 61 70 46 16 58 6 178* E-0 1 1 0 0 0
 39 1 63 12 6 28 59 30 180* A 1 1 0 0 0
 40 1 34 80 28 1 72 45 172* B-0 1 1 0 0 0
 41 1 12 80 28 35 89 30 170* E-0, E-1 3 3 0 0 0
 42 1 34 70 28 4 90 45 169* E-0 1 1 0 0 0
 43 1 12 65 45 4 88 26 168* E-0 1 1 0 0 0
 44 11 27 14 21 15 22 15 174* B-0 1 1 0 0 0
 45 21 35 2 28 22 52 4 144* C-1 1 1 0 0 0
 46 1 64 76 1 23 81 32 181* A 1 1 0 0 0
 47 10 12 4 11 1 9 30 142* A 3 3 0 0 0
          Total 388 116 (30) 169 (44) 89 (23) 14 (4)
Figure 2. Rep-PCR banding patterns and STs of 388 isolates of A. baumannii. Isolates that showed .95% similarity were assigned the same banding
pattern number, and a small letter (a–e) was given to isolates with .90% similarity. The asterisks indicate novel STs found in this study. Open circles
indicate the number of isolates that belonged to group E.
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single clonal complex (CC92) because they share six of seven
housekeeping gene loci. The results of the Institute Pasteur
MLST scheme also supported the clonal relatedness of the iso-
lates in a broader sense, in that they share an identical ST, ST2.
CC92 also includes other single-locus variants of ST92, including
ST118 (1-3-3-2-2-3-3) identified from an isolate from France,
ST88 (1-3-3-2-2-10-3) and ST90 (1-3-3-2-2-62-3) from China,
and ST4 (1-12-3-2-2-7-3) from the UK. Therefore, clonal expan-
sion of A. baumannii CC92 may be the main cause of the recent
worldwide dissemination of CNSAB.
A. baumannii isolates clustered into five groups according to
the sequence of zone 2 of the rpoB gene. Grouping correlated
well with the carbapenem resistance profiles of the A. baumannii
isolates. All 272 CNSAB isolates belonged to subgroup B-0, while
all of the isolates belonging to the other groups were susceptible
to carbapenems. Subgroup B-0 comprised 37 carbapenem-
susceptible isolates and 272 CNSAB isolates, including 169 iso-
lates carrying the blaOXA-23 gene, 89 isolates carrying the
ISAba1 element upstream of the blaOXA-51-like gene and 14 iso-
lates carrying both (Figure 2). It was interesting that only A. bau-
mannii isolates with the single G428T substitution in zone 2 of
the rpoB gene acquired carbapenem-resistance determinants.
Further studies are needed to investigate the reasons for these
phenomena.
While the blaOXA-23 gene has mainly been detected in
A. baumannii, reports of NBA isolates harbouring the OXA carba-
penemase are rare. Recently, two Acinetobacter genomospecies
3 isolates carrying the blaOXA-23 gene were reported in the Irish
Republic.20 One Acinetobacter genomospecies 3 isolate harbour-
ing chromosome-borne OXA-23 was identified in this study. To
our knowledge, this is the second report of an OXA-23-producing
NBA isolate.
In this study, only 1 of 403 A. baumannii isolates was ident-
ified as colistin resistant, in contrast to results reported by Ko
et al.9 Interestingly, both Acinetobacter genomospecies 14TU iso-
lates showed resistance to colistin. Furthermore, the Acinetobac-
ter genomospecies 14TU ATCC 17905 reference strain also
showed resistance to colistin. These results suggest that the Aci-
netobacter genomospecies 14TU may be intrinsically resistant to
colistin, as described by Nemec et al.21
In conclusion, CNSAB isolates of CC92 with a G428T substi-
tution in zone 2 of the rpoB gene were widely disseminated in
Korea, as has been reported in European countries and China.
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